It’s not just the drug industry stepping up its effort to influence the public and policymakers over the increasingly heated battle over the 340B program.
Groups that represent 340B hospitals and hospital pharmacists have launched a digital advertising campaign “to show policymakers and health care leaders how drug companies’ egregious and unlawful restrictions on 340B contract pharmacies are harming low-income patients, providers, and communities,” a spokesperson for one of the groups said.
Groups that represent 340B hospitals and hospital pharmacists have launched a digital advertising campaign “to show policymakers and health care leaders how drug companies’ egregious and unlawful restrictions on 340B contract pharmacies are harming low-income patients, providers, and communities,” a spokesperson for one of the groups said.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
